Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 661
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
for
Pulmonary Invasive Fungal Infections,
Location: Milwaukee WI, Chicago IL, Saint Paul MN,
Sponsor: Arkansas Children's Hospital Research Institute
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Milwaukee WI, Ann Arbor MI, Peoria IL, Urbana IL,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Milwaukee WI, Madison WI, Skokie IL, Chicago IL,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Milwaukee WI, Grand Rapids MI, Peoria IL, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Vitamin D for Prostate Endocrine Therapy
for
Stage I Prostate Cancer AJCC v8,
Location: Green Bay WI, Sturgeon Bay WI, La Crosse WI,
Sponsor: University of Rochester
Sex: Male
Age: 50+
Code: NCT05838716
Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Green Bay WI, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
for
Clinical Stage III Gastric Cancer AJCC v8,
Location: Green Bay WI, Nashville TN, Jacksonville FL, Weston FL,
Sponsor: Academic and Community Cancer Research United
Sex: All
Age: 18+
Code: NCT04660760
Phase2, Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for
Malignant Digestive System Neoplasm,
Location: Green Bay WI, Wausau WI, Chippewa Falls WI, Chelsea MI,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 18+
Code: NCT07215624
Recruiting
Quality of End-of-Life Care for Children With Cancer
for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Green Bay WI, Grand Rapids MI, Kalamazoo MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 18+
Code: NCT07412002
Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Green Bay WI, Madison WI, Grand Rapids MI, Chicago IL,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT07022678
Phase3, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Green Bay WI, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for
B Acute Lymphoblastic Leukemia
Location: Green Bay WI, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 46
Code: NCT06124157
Phase2, Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
for
Recurrent Langerhans Cell Histiocytosis,
Location: Green Bay WI, Milwaukee WI, Grand Rapids MI, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 22
Code: NCT05828069
Phase2, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Green Bay WI, Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT